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Abstract
Background: Unusual metastatic presentation of intra-ocular melanoma.
Study Design: Case report.
Discussion: Extra-regional lymphatic spread of intra-ocular melanoma has not been reported previously in the
literature. The usual pattern of metastasis for intra-ocular melanoma is hematogenous. There are few reports of
regional spread to the maxillofacial bones. We report an interesting case of a 51 year old female with prior history
of right eye melanoma, now presenting with metastasis to the left axilla, which is an extra-regional nodal basin.
Conclusion: In female patients presenting with an isolated axillary mass, with a negative breast work up and
known prior history of melanoma, the differential diagnosis should include possible metastatic melanoma. Core
biopsy will confirm the diagnosis and tailor subsequent management.
Introduction
Ocular melanoma is the most common type of eye can-
cer among adults followed by intra-ocular lymphoma.
Melanoma develops from pigment producing cells called
melanocytes. 90% of the intra-ocular melanomas develop
in the choroid (which is part of the uvea). The etiology
is unknown. There are studies to indicate the role of
sunlight or artificial exposure to ultra-violet radiation
(UVR), but the evidence is mixed [1,2]. Regional lymph
node metastasis from choroidal melanoma is extremely
rare. Here we report an unusual case of a lady diag-
nosed with choroidal melanoma metastatic to an axillary
lymph node. Reports of metastasis to extra-regional
lymph node basins such as the axilla have not been
reported thus far based upon our review of the literature
which makes this case unique.
Case Report
A 51 year old Caucasian lady presented to the breast
care center with two week duration of left axillary mass.
No other breast symptoms. Past medical history is sig-
nificant for right eye choroidal melanoma diagnosed 1.5
years ago treated with brachytherapy and followed at an
eye institute.
At the time of her diagnosis, the patient was having
right eye visual field defect which prompted the evalua-
tion, and the melanoma was noted to be 16 mm in dia-
meter with 9.3 mm thickness, choroidal location, with
inferior hemi-retinal detachment. She is still under fol-
low-up care from the eye institute with clinical response
to the brachytherapy treatment. She had a dermatologic
examination of the whole body to document no cuta-
neous sites of concern. Family history is significant for
her father, paternal aunt, and paternal first cousin who
were diagnosed with cutaneous melanoma and under-
went treatment.
Physical examination was within normal limits with
the exception of the left axilla where there is a 2 cm × 2
cm, freely mobile, non-tender, lymph node. Mammo-
grams from three weeks prior were within normal limits.
Ultrasound of the left axilla done a week prior to the
evaluation (Figure 1) showed an irregular mass, 2.0 ×
1 . 6×2 . 0c mi ns i z e ,h y p o - e c h o i c ,h e t e r o g e n e o u s ,w i t h
some peripheral blood flow. No edge artifact, no poster-
ior acoustic enhancement or shadowing consistent with
BIRADS 4 imaging.
Subsequently, the patient underwent an ultrasound
guided left axillary mass core biopsy (Figure 2). Pathology
on the core biopsy demonstrated metastatic spindle cell
melanoma with necrosis (Figure 3). The patient under-
went extensive staging workup including a PET/CT scan
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along the left mid-axillary line in the axilla. There was
resolution of anatomic findings related to the right
orbit (initial site of melanoma) and no adenopathy
elsewhere. The solid organs were within normal limits.
She was referred to an NCI designated tertiary Insti-
tute for a consultation regarding clinical trials for sys-
temic therapy involving interferon based versus surgery
and observation.
Discussion
The incidence of intra-ocular melanomas has been
stable over the last 25 years, at 6 cases per1 million
population [1-8]. Risk factors for intra-ocular melanoma
include Caucasian race, light skin and or eye color, dys-
plastic nevus syndrome, oculo-dermal melanocytosis
(nevus of Ota), sun exposure, occupation exposure
(welders, chemical workers). The etiology for the most
part is multi-factorial or unknown [2].
Figure 1 Ultrasound image of the irregular mass in the left axilla.
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symptoms. Symptoms however can include blurry
vision, loss of vision, floaters, visual field loss (as in our
patient), growing dark spot on the iris, alteration in the
size or shape of the pupil, change in the position of the
eyeball, bulging of the eye, change in eye movements,
and light sensitivity. Pain is a very rare symptom [2,3].
Most of the time a comprehensive eye exam alone by an
Ophthalmologist can make the diagnosis [4]. Rarely an
ultrasound or a biopsy is needed. Intra-ocular melanomas
are generally made up of two different kinds of cells
namely, spindle (long, thin cells) and epitheloid (round,
straight) cells. Most tumors are composed of both kinds of
these cells. Epitheloid tumors are more likely to metasta-
size to distant sites than spindle cell variant (which is the
histology in this case). The mode of metastasis is hemato-
genous for both histological subtypes, with the first site
being the liver [3,4]. Tumor size is a significant prognostic
Figure 2 The image shows the ultrasound guided core biopsy of the left axillary mass.
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Extra-ocular spread to other organs such as lung, gastroin-
testinal tract, skin, bones, central nervous system, has been
seen in association with liver metastases [5,6].
There are very few case reports of regional lymph
node metastasis from an intra-ocular melanoma. These
studies reported spread of choroidal melanoma into the
conjunctiva via regional lymphatics [5] and or spread to
the maxillofacial bones [6]. Extra-ocular distant lympha-
tic spread (outside the regional lymph node basin) has
not been demonstrated in intra-ocular choroidal mela-
nomas due to the absence of lymphatics in the choroid.
There is some research and speculation on intraocular
lymphangiogenesis in melanomas of the ciliary body and
if that could explain extra-ocular lymph node spread or
extension [7]. The case we present is unusual as it
demonstrates lymphatic spread of choroidal melanoma
outside the eye to an extra-regional lymph node basin
which has not been reported previously in the literature.
Prognosis of intra-ocular melanoma depends upon the
stage of the disease. Staging for melanoma of the eye differs
from cutaneous melanoma. Furthermore melanoma invol-
ving the iris has a separate T staging than the melanoma
involving the ciliary body/choroidal plexus. Cancer spread
involving different parts of the body, like the scenario in
this case, is Stage IV. Survival rate for patients with Stage
IV melanoma at 5 years is approximately 15% [8,9].
Surgical therapy of choroidal melanoma traditionally
involves enucleation. Brachytherapy, also known as
episcleral plaque therapy, can be used as a primary
treatment modality. Some studies have shown that in
many cases it is as effective as enucleation [8,9].
Conclusion
Most melanomas of the eye involve the choroid. The
diagnosis is often clinically made by an Ophthalmologist.
The pattern of metastatic spread has been traditionally
thought to be hematogenous, liver being the first site.
This case illustrates that intra-ocular melanoma has the
potential to metastasize to extra-ocular distant lymphatic
basin. Unusual metastasis poses a diagnostic and thera-
peutic challenge.
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Figure 3 Histopathology image of the core biopsy showing metastatic spindle cell melanoma.
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